Research AppraisalSystematic Review

Neural substrates of apathy in Parkinson's disease: A systematic review of structural and functional neuroimaging studies

Brain research bulletinMarafioti, Giulia, Culicetto, Laura, Blundo, Carlo et al.15 June 2026DOI

Clinical Snapshot

65CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationPatients with Parkinson's disease with and without apathy, compared to healthy controls
I — InterventionNeuroimaging assessment (structural MRI, functional MRI, DTI, PET/SPECT)
C — ComparatorPD patients without apathy and healthy controls
O — OutcomesNeural correlates of apathy including structural, functional, and molecular brain alterations

Bottom Line

This systematic review identifies consistent involvement of fronto-striatal-limbic networks in apathy among Parkinson's disease patients, with particular alterations in dorsolateral prefrontal cortex, anterior cingulate, and nucleus accumbens. However, significant methodological heterogeneity across the 16 included studies prevents definitive conclusions about a unified neural signature. While the findings advance our understanding of apathy's neurobiological basis in PD, the evidence remains insufficient to guide clinical decision-making or treatment stratification. The review highlights the need for standardized apathy assessment tools and harmonized neuroimaging protocols in future research. Clinicians should continue relying on validated clinical scales for apathy assessment rather than neuroimaging markers, while recognizing that apathy represents a distinct neuropsychiatric syndrome partially dissociable from depression in PD patients.

Evidence: Moderate

Key Findings

  • P Value: Not reported - qualitative synthesis

  • Effect Size: Not quantified - narrative synthesis only

  • Primary Outcome: Fronto-striatal-limbic network alterations in apathetic PD patients

  • Nnt Or Sensitivity: Correlations with apathy severity reported but not quantified across studies

  • Confidence Interval: Not applicable - no meta-analysis performed

Clinical Application

Limited clinical utility as no unified imaging signature identified for diagnostic or prognostic purposes Relevant for Australian neurologists and psychiatrists managing PD patients, though neuroimaging findings not yet ready for routine clinical application. May inform future research directions in Australian movement disorder centres Parkinson's disease patients presenting with apathy symptoms in movement disorder clinics

Abstract

BACKGROUND: Apathy is a frequent and disabling non-motor symptom in Parkinson's disease (PD), characterized by diminished motivation, reduced goal-directed behavior, and emotional indifference. Growing evidence suggests that apathy in PD represents a distinct neuropsychiatric syndrome that may coexist with depression and global cognitive impairment, while also showing partially dissociable clinical and neural correlates. OBJECTIVE: This systematic review aimed to investigate the neural substrates of apathy in PD by synthesizing evidence from structural and functional neuroimaging studies. METHODS: Following PRISMA guidelines, we searched PubMed, Embase, Web of Science, and Scopus for studies assessing apathy in PD through neuroimaging techniques, including structural MRI, resting-state functional MRI, diffusion tensor imaging, PET/SPECT molecular imaging, and connectivity analyses. Apathy severity was evaluated using validated clinical scales, and findings were compared between PD population with and without apathy, as well as healthy controls. RESULTS: Across 16 heterogeneous studies, recurrent findings implicated structural, functional, and molecular alterations within fronto-striatal-limbic networks. However, differences in apathy measures and neuroimaging modalities limit direct comparability across studies and do not support a single unified imaging signature of apathy in PD. Apathetic PD subjects consistently exhibited reduced gray matter volume and altered spontaneous activity in the dorsolateral, inferior frontal gyri, anterior cingulate cortex (ACC), and nucleus accumbens, alongside disrupted functional and structural connectivity in fronto-limbic tracts. These alterations were significantly correlated with apathy severity and, in several studies, remained detectable after accounting for depressive symptoms or global cognitive status. Furthermore, the available findings suggest that apathy in PD may involve heterogeneous neurobiological mechanisms, including variable involvement of frontal, striatal, and limbic circuits; however, current evidence remains insufficient to support firm transmitter-based subtyping or treatment stratification. CONCLUSIONS: Current evidence suggests that apathy in PD involves partially dissociable neural correlates across prefrontal, striatal, and limbic systems. However, methodological heterogeneity across studies limits strong generalization, and future harmonized longitudinal studies are needed to clarify which findings are robust and clinically meaningful.

References

  1. 1.Marafioti, G., Culicetto, L., Blundo, C., Susinna, C., Restuccia, G., Di Lorenzo, G., Quartarone, A., & Lo Buono, V. (2026). Neural substrates of apathy in Parkinson's disease: A systematic review of structural and functional neuroimaging studies. Brain Research Bulletin, 111922. https://doi.org/10.1016/j.brainresbull.2026.111922
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service